Imidazooxazole derivative having antitumor effect,  and pharmaceutical compostion including same

Mahmoud, Gamal El-din; Choi, Hong Seok; Yoo, Kyung Ho; Han, Dong Keun; Oh, Chang Hyun; Mohammed, Abdel-Maksoud; Mohammed, I. El-Gamal; Ammar, Usama

Imidazooxazole derivative having antitumor effect, and pharmaceutical compostion including same

Mahmoud, Gamal El-din; Choi, Hong Seok; Yoo, Kyung Ho; Han, Dong Keun; Oh, Chang Hyun; Mohammed, Abdel-Maksoud; Mohammed, I. El-Gamal; Ammar, Usama

Authors

Gamal El-din Mahmoud

Hong Seok Choi

Kyung Ho Yoo

Dong Keun Han

Chang Hyun Oh

Abdel-Maksoud Mohammed

I. El-Gamal Mohammed

Dr Usama Ammar U.Ammar@napier.ac.uk
Lecturer

Abstract

Provided is a pharmaceutical composition for preventing and treating tumors, the pharmaceutical composition including an imidazooxazole derivative compound, a solvate, a stereoisomer, or a pharmaceutically acceptable salt thereof as an active ingredient. The pharmaceutical composition is administered to an entity which has developed a tumor or is in danger of developing a tumor, and thus tumors can be prevented or treated.

Citation

Mahmoud, G. E.-D., Choi, H. S., Yoo, K. H., Han, D. K., Oh, C. H., Mohammed, A.-M., Mohammed, I. E.-G., & Ammar, U. (2022). Imidazooxazole derivative having antitumor effect, and pharmaceutical compostion including same. US011332479B2

Online Publication Date	May 17, 2022
Publication Date	May 17, 2022
Deposit Date	Dec 11, 2022
Public URL	http://researchrepository.napier.ac.uk/Output/2973589

Abstract 4472: Discovery of potential RAF-selective back pocket as a promising biological target for BRAF inhibitors in the treatment of resistant melanoma: Design, synthesis, biological evaluation and in silico studies (2024)
Presentation / Conference Contribution

Correction: Elsherbeny et al. 2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation. Life 2022, 12, 876 (2024)
Journal Article

Scaffold Repurposing Reveals New Nanomolar Phosphodiesterase Type 5 (PDE5) Inhibitors Based on Pyridopyrazinone Scaffold: Investigation of In Vitro and In Silico Properties (2022)
Journal Article

2-(3-Bromophenyl)-8-fluoroquinazoline-4-carboxylic Acid as a Novel and Selective Aurora A Kinase Inhibitory Lead with Apoptosis Properties: Design, Synthesis, In Vitro and In Silico Biological Evaluation (2022)
Journal Article

Structural optimization of 4-(imidazol-5-yl)pyridine derivatives affords broad-spectrum anticancer agents with selective B-RAFV600E/p38α kinase inhibitory activity: Synthesis, in vitro assays and in silico study (2022)
Journal Article

Downloadable Citations

HTML

BIB

RTF

Authors

Abstract

Citation

You might also like

Downloadable Citations